Svetla Gadzhanova

Svetla Gadzhanova

Adelaide Medical School

Faculty of Health and Medical Sciences

I am currently working within the Discipline of General Practice on quality of life of ASPREE trial participants

I am currently working within the Discipline of General Practice on quality of life in ASPREE trial participants

  • Education
    Date Institution name Country Title
    University of South Australia Australia PhD

  • Journals
    Year Citation
    2024 Le, T. N., Afshar Ali, M., Gadzhanova, S., Lim, R., Bala, I., Bogale, K. N., & Gillam, M. (2024). Hernia repair prevalence by age and gender among the Australian adult population from 2017 to 2021. Critical Public Health, 34(1), 1-11.
    DOI
    2024 Gadzhanova, S., & Roughead, E. (2024). Use of Analgesic and Anti-Inflammatory Medicines before and after Initiation of Biological Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis. Journal of Clinical Pharmacy and Therapeutics, 2024, 7 pages.
    DOI Scopus1
    2021 Park, S. H., Jeon, H. L., Kim, S. C., Hillen, J., Gadzhanova, S., Shin, J. Y., & Pratt, N. (2021). Utilization of targeted disease-modifying anti-rheumatic drugs (DMARDs) for managing rheumatoid arthritis in the last decade: A two-country comparison. International Journal of Clinical Pharmacology and Therapeutics, 59(10), 639-644.
    DOI Scopus1 Europe PMC1
    2021 De Vries, C., Gadzhanova, S., Sykes, M. J., Ward, M., & Roughead, E. (2021). A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants. Drug Safety, 44(3), 291-312.
    DOI Scopus29 Europe PMC8
    2020 Gadzhanova, S., Roughead, E., Lowy, H., & O'Connor, D. (2020). Reducing adverse medication events in mental health: Australian National Survey. International journal of evidence-based healthcare, 18(1), 108-115.
    DOI Scopus2
    2020 Gadzhanova, S., Gillam, M., & Roughead, E. (2020). Risk of falls and injuries requiring hospitalisation after first-eye cataract surgery in elderly Australians. Acta Ophthalmologica, 98(4), e495-e498.
    DOI Scopus3 Europe PMC1
    2019 Caughey, G. E., Gadzhanova, S., Shakib, S., & Roughead, E. E. (2019). Concomitant prescribing of opioids and benzodiazepines in Australia, 2012–2017. Medical Journal of Australia, 210(1), 39-40.
    DOI Scopus8 WoS7 Europe PMC6
    2019 Kalisch Ellett, L. M., Moffat, A. K., Gadzhanova, S., Pratt, N. L., Apajee, J., Woodward, M., & Roughead, E. E. (2019). Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines.. Pharmacy (Basel, Switzerland), 7(3), E100.
    DOI Europe PMC4
    2018 Gadzhanova, S., & Roughead, E. (2018). Comparison of General Practice and Pharmaceutical Dispensing Data for Pharmacoepidemiological Research: Assessing the Risk of Urinary-Tract Infections with Sodium Glucose Cotransporter 2 Inhibitors for Diabetes. ADVANCES IN PUBLIC HEALTH, 2018, 6 pages.
    DOI
    2018 Gadzhanova, S., Roughead, E. E., & Pont, L. G. (2018). Antidepressant switching patterns in the elderly. International Psychogeriatrics, 30(9), 1365-1374.
    DOI Scopus8 Europe PMC2
    2017 Gadzhanova, S., Pratt, N., & Roughead, E. (2017). Use of SGLT2 inhibitors for diabetes and risk of infection: Analysis using general practice records from the NPS MedicineWise MedicineInsight program. Diabetes Research and Clinical Practice, 130, 180-185.
    DOI Scopus44 WoS38 Europe PMC28
    2017 Pratt, N. L., Kalisch Ellett, L. M., Sluggett, J. K., Gadzhanova, S. V., Ramsay, E. N., Kerr, M., . . . Roughead, E. E. (2017). Use of proton pump inhibitors among older Australians: National quality improvement programmes have led to sustained practice change. International Journal for Quality in Health Care, 29(1), 75-82.
    DOI Scopus25 WoS18 Europe PMC19
    2016 Gadzhanova, S., & Roughead, E. (2016). Prescribed antibiotic use in Australian children aged 0-12 years. Australian Family Physician, 45(3), 134-138.
    Scopus11 Europe PMC7
    2016 Gadzhanova, S., Roughead, E. E., & Bartlett, L. E. (2016). Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia. European Journal of Clinical Pharmacology, 72(6), 765-771.
    DOI Scopus7 Europe PMC4
    2016 Shin, H. Y., Gadzhanova, S., Roughead, E. E., Ward, M. B., & Pont, L. G. (2016). The use of antipsychotics among people treated with medications for dementia in residential aged care facilities. International Psychogeriatrics, 28(6), 977-982.
    DOI Scopus11 Europe PMC8
    2015 Gadzhanova, S., Roughead, E. E., & Pont, L. G. (2015). Safety of opioid patch initiation in Australian residential aged care. Medical Journal of Australia, 203(7), 298.e1-298.e6.
    DOI Scopus13 Europe PMC8
    2015 Gadzhanova, S., & Roughead, E. (2015). Use of prescription medicines in Australian women of child-bearing age. BMC Pharmacology and Toxicology, 16(1), 12 pages.
    DOI Scopus6 Europe PMC3
    2015 Gadzhanova, S., Roughead, E., & Robinson, M. (2015). Use of Medicines with Anticholinergic and Sedative Effect Before and After Initiation of Anti-Dementia Medications. Drugs - Real World Outcomes, 2(1), 53-60.
    DOI Scopus13 Europe PMC10
    2015 Gadzhanova, S., & Roughead, E. (2015). Survival after initiation of androgen deprivation therapy for prostate cancer of Australian men. Cancer Epidemiology, 39(6), 854-859.
    DOI Scopus2
    2013 Gadzhanova, S., Ilomäki, J., & Roughead, E. E. (2013). COX-2 inhibitor and non-selective NSAID use in those at increased risk of NSAID-related adverse events: A retrospective database study. Drugs and Aging, 30(1), 23-30.
    DOI Scopus8 Europe PMC4
    2013 Gadzhanova, S. V., Roughead, E. E., & Bartlett, M. J. (2013). Improving cardiovascular disease management in Australia: NPS MedicineWise. Medical Journal of Australia, 199(3), 192-195.
    DOI Scopus10 Europe PMC7
    2013 Gadzhanova, S., Bell, J. S., & Roughead, E. E. (2013). What analgesics do older people use prior to initiating oxycodone for non-cancer pain? A retrospective database study. Drugs and Aging, 30(11), 921-926.
    DOI Scopus16 Europe PMC14
    2013 Gadzhanova, S., Ilomäki, J., & Roughead, E. E. (2013). Antihypertensive use before and after initiation of fixed-dose combination products in Australia: A retrospective study. International Journal of Clinical Pharmacy, 35(4), 613-620.
    DOI Scopus7 Europe PMC2
    2012 Gadzhanova, S. V., Roughead, E. E., & Mackson, J. M. (2012). Initiation and duration of proton pump inhibitors in the Australian veteran population. Internal Medicine Journal, 42(5), e68-e73.
    DOI Scopus14 Europe PMC10
    2011 Gadzhanova, S., Roughead, E. E., Loukas, K., & Vajda, J. (2011). Improvement in metformin and insulin utilisation in the Australian veteran population associated with quality use of medicines intervention programs. Pharmacoepidemiology and Drug Safety, 20(4), 359-365.
    DOI Scopus4 Europe PMC2
    2011 Gadzhanova, S., Gillies, M., Roughead, E., & Zuo, Y. (2011). Fixed dose combination diabetes medicines: Usage in the Australian veteran population. Australian Family Physician, 40(10), 811-815.
    Scopus5 Europe PMC2
    2010 Gadzhanova, S., Roughead, L., & MacKson, J. (2010). Anticholinesterase duration in the Australian veteran population. Australian and New Zealand Journal of Psychiatry, 44(5), 469-474.
    DOI Scopus11 Europe PMC9
    2007 Gadzhanova, S., Iankov, I., Warren, J., Stanek, J., Misan, G., Baig, M., & Ponte, L. (2007). Developing high-specificity anti-hypertensive alerts by therapeutic state analysis of electronic prescribing records. Journal of the American Medical Informatics Association, 14(1), 100-109.
    DOI Scopus6 WoS4 Europe PMC2
    2007 Gadzhanova, S., & Reed, R. (2007). Medical services provided by general practitioners in residential aged-care facilities in Australia. Medical Journal of Australia, 187(2), 92-94.
    DOI Scopus30 Europe PMC18
    2005 Warren, J., Gadzhanova, S., Stanek, J., & Iankov, I. (2005). Understanding caseload and practice through analysis of therapeutic state transitions.. AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium, 2005, 784-788.
    Scopus4

  • Conference Items
    Year Citation
    2017 Caughey, G. E., Gadzhanova, S., Shakib, S., & Roughead, E. E. (2017). Trends in Concomitant Prescribing of Opioids and Benzodiazepines in Australia 2010-2015; a Cause for Concern?. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY.

  • Preprint
    Year Citation
    2020 De Vries, C., Gadzhanova, S., Sykes, M. J., Ward, M., & Roughead, E. (2020). A systematic review and meta-analysis considering the SSRI, SNRI and TCA classes of antidepressants and the risk for congenital heart defects.
    DOI
Connect With Me
External Profiles